⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for lenalidomide and rituximab

Every month we try and update this database with for lenalidomide and rituximab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)NCT00628238
Chronic Lymphoc...
CLL
Untreated
Front-line
First-Line
Initial Therapy
Lenalidomide an...
Lenalidomide an...
- Chronic Lymphocytic Leukemia Research Consortium
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)NCT00628238
Chronic Lymphoc...
CLL
Untreated
Front-line
First-Line
Initial Therapy
Lenalidomide an...
Lenalidomide an...
- Chronic Lymphocytic Leukemia Research Consortium
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: